Ultane — Class III drug recall D-0412-2018
Terminated recall by AbbVie Inc., reported 2018-02-07, distributed in MS, OH. Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing pos
| Recall number | D-0412-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc., North Chicago, IL, United States |
| Recall initiated | 2018-01-22 |
| Classified | 2018-02-09 |
| Reported by FDA | 2018-02-07 |
| Terminated | 2018-09-13 |
| Distributed | MS, OH |
| Quantity | 7,770 bottles |
| Reason classes | packaging |
| NDC | 00074-4456, 00074-4456-51 |
| Lot numbers | 1088856, 6/20 |
Product
Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51
Reason for recall
Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0412-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.